ReadYourDNA

Alendronate (Fosamax)

Raw research findings for this medication. Mostly single studies, not curated or confirmed robust.

About Alendronate

What it is

Alendronate is a bisphosphonate: it binds to bone and slows the osteoclasts that break bone down, so bone density is kept or improves and fractures become less likely. It is taken as a weekly tablet for osteoporosis, including that caused by long-term steroid use, and for Paget's disease of bone. It is sold as Fosamax and Binosto, among other names.

How genes come into it

Alendronate is not broken down; what is not taken up into bone is cleared by the kidneys. Studies have looked at genes of bone turnover for how much bone density improved, such as TNFRSF11A (the RANK receptor), the vitamin D receptor VDR and MVK in the pathway alendronate blocks. The findings come from a few studies, and there is no CPIC or DPWG guideline.

What research found

Every published finding on gene variants and Alendronate. Upload your DNA file to see which of these rows apply to you.

Rated evidence (2 rated variants)

PharmGKB weighs all studies of a variant and rates how strong the evidence is, from 1A (strongest) to 4.

VDR rs1544410: Level 3. Efficacy: Osteoporosis. 2.

MVK rs10161126: Level 3. Efficacy: Bone Diseases. 1.

Response (9 findings)

Studies of how well it worked in people carrying a variant.

MVK rs10161126: Genotype GG is associated with increased response to alendronate in women with Bone Diseases as compared to genotypes AA + AG.

TNFRSF11A rs11877530: Allele G is not associated with response to alendronate in women with Osteoporosis as compared to allele A.

TNFRSF11A rs12969154: Allele G is not associated with response to alendronate in women with Osteoporosis as compared to allele A.

TNFRSF11A rs17069895: Allele C is not associated with response to alendronate in women with Osteoporosis as compared to allele T.

Study findings and evidence levels: PharmGKB (CC BY-SA 4.0). Guidelines: CPIC and DPWG, as bundled in PharmCAT. Most studies were done mainly in people of European ancestry.

Related Drugs

More drugs from the same category

Actonel (Bisphosphonates)

Bisphosphonates (class) (Bisphosphonates)

Bonefos (Bisphosphonates)

Not a prescribing recommendation. This page is educational information about pharmacogenomic research and clinical guidelines - it is not medical or dosing advice, and not a prediction of how any medication will work for you. Never start, stop, or change a medication or dose based on it; talk to your doctor or pharmacist, who can order clinical-grade testing if appropriate.

Back to Medications

Content updated September 2026.

ReadYourDNA provides educational interpretation of DNA data you already have. It is not diagnostic, not a substitute for professional medical advice, diagnosis, or treatment, and is not intended to diagnose, treat, cure, or prevent any disease. Talk to a clinician before acting on any result.

Raw DNA Data Reports for 23andMe & AncestryDNA · About ReadYourDNA · FAQ · Methodology & Science · Pricing · Support and complaints · Legal & Contact · Health Traits · Pharmacogenomics · Carrier Status · Variant Explorer · The Human Karyotype · Privacy Policy · Terms of Service · Accessibility · Consumer Health Data Privacy · Your Privacy Choices · Editorial Standards · Your Data, Checkable · Sample Report · ReadYourDNA and Promethease compared · What is inside a 23andMe raw data file · What is inside an AncestryDNA raw data file · What a chatbot can and cannot do with your raw DNA file · Where a raw DNA file can still be uploaded in 2026

Written, maintained and operated by Martin Pechhacker, sole proprietor, Vienna, Austria. Trade register GISA 40064420. support@readyourdna.com